U.S. Markets open in 6 hrs 28 mins

AgeX Therapeutics, Inc. (AGE)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.8950-0.0050 (-0.26%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.9000
Open1.9800
Bid0.0000 x 2900
Ask0.0000 x 2900
Day's Range1.8800 - 1.9800
52 Week Range0.6660 - 3.9300
Volume310,990
Avg. Volume275,854
Market Cap71.424M
Beta (5Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)-0.2960
Earnings DateNov 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • AgeX Therapeutics, Inc. Announces That Its Annual Meeting of Stockholders Will Be Conducted Online Only
    Business Wire

    AgeX Therapeutics, Inc. Announces That Its Annual Meeting of Stockholders Will Be Conducted Online Only

    AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE) announced today that due to state and county government health orders, attendance at the AgeX 2020 Annual Meeting of Stockholders (the "Annual Meeting") to be held at 10:00 a.m. Pacific Standard Time on Monday, December 28, 2020 will be permitted only through online participation. The County of Alameda, California, where AgeX’s offices are located and where AgeX had planned to hold the Annual Meeting, has issued Health Officer Order 20-21 (the "Order") restricting or prohibiting many business activities due to the COVID-19 pandemic. The Order provides that offices must close and business must be conducted remotely, except in critical infrastructure sectors where remote work is not possible.

  • Where Do Hedge Funds Stand On AgeX Therapeutics, Inc. (AGE)?
    Insider Monkey

    Where Do Hedge Funds Stand On AgeX Therapeutics, Inc. (AGE)?

    Is AgeX Therapeutics, Inc. (NYSE:AGE) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to […]

  • AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
    Business Wire

    AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update

    AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing innovative regenerative therapeutics to treat human diseases to increase healthspan and combat the effects of aging, reported financial and operating results for the third quarter ended September 30, 2020.